Semantic Scholar uses AI to extract papers important to this topic.
Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
- The Journal of endocrinology
Human melanocortin 4 receptor (hMC4R) mutations with in vitro functional effects are responsible for 0.5-2.5% of severe obesity… (More)
Is this relevant?